Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuropeptide Y receptor subtype 5 (Y5) is a G protein-coupled receptor that binds neuropeptide Y (NPY) and peptide YY (PYY). It is involved in regulating food intake, fat accumulation, and seizure modulation. It is located at the cell membrane and primarily signals via G proteins that inhibit adenylate cyclase activity. The Y5 receptor is implicated in feeding behavior, obesity, and may also play a role in certain cancers. It is a therapeutic target of interest for obesity prevention/treatment and radiopharmaceuticals relevant to cancer imaging or therapy.
Acts as a receptor for neuropeptide Y (NPY) and peptide YY (PYY), mediating effects via G proteins that inhibit adenylate cyclase activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuropeptide Y receptor subtype 5 (Y5).